DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients. [PDF]
Medicine (Baltimore), 2019 Hidalgo-Tenorio C +11 more
europepmc +1 more source
Pharmacoeconomic analysis of antibiotic therapy in maxillofacial surgery. [PDF]
BDJ Open, 2017 Orzechowska-Wylęgała B +4 more
europepmc +1 more source
Factors influencing medical expenditures in patients with unresolved facial palsy and pharmacoeconomic analysis of upper eyelid lid loading with gold and platinum weights compared to tarsorrhaphy. [PDF]
Health Econ RevNowak-Gospodarowicz I +2 more
europepmc +1 more source
Pharmacoeconomic Analysis of Antiepileptic Reimbursement for Neuropathic Pain in Bosnia and Herzegovina - Budget Impact Analysis of Pregabalin. [PDF]
Mater Sociomed, 2018 Catic T, Jusufovic R, Tabakovic V.
europepmc +1 more source
A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus. [PDF]
J Family Med Prim Care, 2019 Tandon T +5 more
europepmc +1 more source
Obstetric pharmacoeconomics. [PDF]
Expert Rev Pharmacoecon Outcomes ResEke AC, Igbodike EP.
europepmc +1 more source
Pharmacoeconomic Analysis of Drugs Used in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India-A Cost-of-Illness Study. [PDF]
Med Sci (Basel), 2017 Saha L +4 more
europepmc +1 more source
miR-1246 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Breast Cancer: A Narrative Review With Pharmacoeconomic Perspectives. [PDF]
Health Sci RepGhaith A, Hussein LA.
europepmc +1 more source
A pharmacoeconomic evaluation of aprepitant injection versus aprepitant capsules for the prevention of CINV caused by moderately and highly emetogenic chemotherapy. [PDF]
Front PharmacolChen Z +6 more
europepmc +1 more source